{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:50:49Z","timestamp":1791089449976,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T00:00:00Z","timestamp":1378512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1245\/s10434-013-3245-6","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T13:39:07Z","timestamp":1378474747000},"page":"42-50","source":"Crossref","is-referenced-by-count":17,"title":["Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional pN Staging"],"prefix":"10.1245","volume":"21","author":[{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,7]]},"reference":[{"key":"3245_CR1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672\u201385.","journal-title":"J Clin Oncol."},{"key":"3245_CR2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.1999.17.2.460","volume":"17","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999;17:460\u20139.","journal-title":"J Clin Oncol."},{"key":"3245_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26:778\u201385.","journal-title":"J Clin Oncol."},{"key":"3245_CR4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/annonc\/mdn761","volume":"20","author":"V Guarneri","year":"2009","unstructured":"Guarneri V, Piacentini F, Ficarra G, et al. A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. Ann Oncol. 2009;20:1193\u20138.","journal-title":"Ann Oncol."},{"key":"3245_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-008-0081-7","volume":"116","author":"RL Jones","year":"2009","unstructured":"Jones RL, Salter J, A\u2019Hern R, et al. The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat. 2009;116:53\u201368.","journal-title":"Breast Cancer Res Treat."},{"key":"3245_CR6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/annonc\/mdn747","volume":"20","author":"M Colleoni","year":"2009","unstructured":"Colleoni M, Bagnardi V, Rotmensz N, et al. A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. Ann Oncol. 2009;20:1178\u201384.","journal-title":"Ann Oncol."},{"key":"3245_CR7","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1200\/JCO.2005.01.2898","volume":"23","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Pusztai L, Delaloge S, et al. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol. 2005;23:8331\u20139.","journal-title":"J Clin Oncol."},{"key":"3245_CR8","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25:4414\u201322.","journal-title":"J Clin Oncol."},{"key":"3245_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10434-000-0435-9","volume":"7","author":"F Meric","year":"2000","unstructured":"Meric F, Mirza NQ, Buzdar AU, et al. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer. Ann Surg Oncol. 2000;7:435\u201340.","journal-title":"Ann Surg Oncol."},{"key":"3245_CR10","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.20969","volume":"103","author":"PT Truong","year":"2005","unstructured":"Truong PT, Berthelet E, Lee J, et al. The prognostic significance of the percentage of positive\/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer. 2005;103:2006\u201314.","journal-title":"Cancer."},{"key":"3245_CR11","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1200\/JCO.2009.24.0044","volume":"27","author":"V Belle Van","year":"2009","unstructured":"Van Belle V, Van Calster B, Wildiers H, et al. Lymph node ratio better predicts disease-free survival in node-positive breast cancer than the number of positive lymph nodes. J Clin Oncol. 2009;27:e150\u20131; author reply e152.","journal-title":"J Clin Oncol."},{"key":"3245_CR12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.2008.18.6965","volume":"27","author":"V Vinh-Hung","year":"2009","unstructured":"Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27:1062\u20138.","journal-title":"J Clin Oncol."},{"key":"3245_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.amjsurg.2005.08.041","volume":"191","author":"H Neuman","year":"2006","unstructured":"Neuman H, Carey LA, Ollila DW, et al. Axillary lymph node count is lower after neoadjuvant chemotherapy. Am J Surg. 2006;191:827\u20139.","journal-title":"Am J Surg."},{"key":"3245_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer."},{"key":"3245_CR15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jcp.2003.015560","volume":"57","author":"JE Somner","year":"2004","unstructured":"Somner JE, Dixon JM, Thomas JS. Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol. 2004;57:845\u20138.","journal-title":"J Clin Pathol."},{"key":"3245_CR16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jamcollsurg.2007.10.016","volume":"206","author":"J Belanger","year":"2008","unstructured":"Belanger J, Soucy G, Sideris L, et al. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count. J Am Coll Surg. 2008;206:704\u20138.","journal-title":"J Am Coll Surg."},{"key":"3245_CR17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4048\/jbc.2011.14.3.204","volume":"14","author":"JY Kim","year":"2011","unstructured":"Kim JY, Ryu MR, Choi BO, et al. The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer. J Breast Cancer. 2011;14:204\u201312.","journal-title":"J Breast Cancer."},{"key":"3245_CR18","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1245\/s10434-011-2189-y","volume":"19","author":"C Tausch","year":"2012","unstructured":"Tausch C, Taucher S, Dubsky P, et al. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Ann Surg Oncol. 2012;19:1808\u201317.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"3245_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.clbc.2012.07.009","volume":"12","author":"F Wang","year":"2012","unstructured":"Wang F, He W, Qiu H, et al. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer. Clin Breast Cancer. 2012;12(6):404\u201311.","journal-title":"Clin Breast Cancer."},{"key":"3245_CR20","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2217\/fon.09.129","volume":"5","author":"V Vinh-Hung","year":"2009","unstructured":"Vinh-Hung V, Nguyen NP, Cserni G, et al. Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol. 2009;5:1585\u2013603.","journal-title":"Future Oncol."},{"key":"3245_CR21","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1200\/JCO.2005.03.1526","volume":"24","author":"WA Woodward","year":"2006","unstructured":"Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910\u20136.","journal-title":"J Clin Oncol."},{"key":"3245_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-008-0160-9","volume":"116","author":"B Keam","year":"2009","unstructured":"Keam B, Im SA, Kim HJ et al. Clinical significance of axillary nodal ratio in stage II\/III breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat. 2009;116:153\u201360.","journal-title":"Breast Cancer Res Treat."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3245-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-3245-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3245-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T13:58:16Z","timestamp":1563890296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-3245-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["3245"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-3245-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,7]]}}}